Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.
The anticancer drug cisplatin executes its cytotoxic activity via formation of intra- and interstrand crosslinks in DNA. The relative contribution of structurally defined cisplatin adducts to induce apoptosis and the cellular processing of these lesions is still poorly understood mostly due to the lack of sensitive analytical tools for in vivo studies. Here we describe a new method to establish and characterize monoclonal antibodies (Mab) for structurally defined DNA adducts. The two major reaction products of cisplatin, the guanine-guanine (Pt-[GG]) and adenine-guanine (Pt-[AG]) intrastrand crosslinks are recognized by Mab R-C18 and R-B3, respectively. Both antibodies were employed in an immuno-cytological assay allowing the quantification of drug-induced lesions in individual cell nuclei at clinically relevant doses. Analyzing various tissues of cisplatin-treated C57Bl/6 mice the accumulation of Pt-(GG) was highest in kidney tubular cells compared with 30, 50 and 90% lower levels in kidney stroma, liver and peripheral blood cells, respectively. Adduct kinetics revealed that wild type mouse cells remove up to 80% of the crosslinks in contrast to their complete persistence in nucleotide excision repair-deficient (XPC-/-) mice. The aptitude of the immunoassay for human molecular dosimetry studies was demonstrated by measuring adduct levels in tumor biopsies from patients treated with cisplatin.
Institut für Zellbiologie, Universitätsklinikum, Essen Germany.
Bernd
B
Liedert
Dick
D
Pluim
Jan
J
Schellens
Jürgen
J
Thomale
D000225:Adenine / Q000031:analogs & derivatives* / Q000032:analysis / Q000276:immunology*; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000918:Antibody Specificity; D000970:Antineoplastic Agents / Q000633:toxicity; D002467:Cell Nucleus / Q000737:chemistry; D002945:Cisplatin / Q000633:toxicity; D018736:DNA Adducts / Q000032:analysis / Q000276:immunology*; D004249:DNA Damage; D004260:DNA Repair; D019084:Fluorescent Antibody Technique, Indirect; D006147:Guanine / Q000031:analogs & derivatives* / Q000032:analysis / Q000276:immunology*; D006801:Humans; D006825:Hybridomas; D007118:Immunoassay / Q000379:methods; D019169:Jurkat Cells; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D013274:Stomach Neoplasms / Q000737:chemistry / Q000473:pathology
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D018736:DNA Adducts; D006147:Guanine; D000225:Adenine; D002945:Cisplatin